Results 61 to 70 of about 21,946 (228)

Early or late amniocentesis – which method is safer? [PDF]

open access: yes, 1970
Objectives: Whether or not to perform early or late amniocentesis remains questionable due to higher fetal loss and the rate of talipes equinovarus after early amniocentesis.
Świątkowska-Freund, Małgorzata   +3 more
core  

Mosaic trisomy 17 at amniocentesis: Prenatal diagnosis, molecular genetic analysis, and literature review

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2016
Objective: We present prenatal diagnosis and molecular genetic analysis of mosaic trisomy 17 and a review of the literature of mosaic trisomy 17 at amniocentesis. Materials and Methods: A 42-year-old woman underwent amniocentesis at 17 weeks of gestation
Chih-Ping Chen   +9 more
doaj   +1 more source

Attitudes Toward Prenatal Interventions in the Fanconi Anemia Community

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Objective In‐utero cell and gene therapies may offer prenatal treatment options for inherited diseases. Preclinical data suggests in‐utero (IU) hematopoietic stem cell transplantation (HSCT) could prevent Fanconi anemia (FA) related bone marrow failure without genotoxic conditioning or immune suppression.
Tony Lum   +4 more
wiley   +1 more source

Information and decision support needs of parents considering amniocentesis: interviews with pregnant women and health professionals [PDF]

open access: yes, 2020
Objective Our aim was to clarify and categorize information and decision support needs of pregnant women deciding about amniocentesis. Background Prenatal screening for DownÕs syndrome (implemented in routine practice) generates a quantifiable risk of ...
Mareike Stiel Bsc   +4 more
core  

Exploring Women’s Experiences of Amniocentesis: A Qualitative Content Analysis

open access: yesIranian Journal of Nursing and Midwifery Research
Background: The decision and experience of high-risk pregnant women to undergo amniocentesis can depend on their setting, context, social structures, and significant others, including cultural values and beliefs.
Jaruwan Kownaklai   +2 more
doaj   +1 more source

Unbalanced and Balanced Acrocentric Rearrangements Involving Chromosomes Other Than Chromosome 21 at Amniocentesis

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2009
Objective: To investigate unbalanced and balanced acrocentric rearrangements involving chromosomes other than chromosome 21 at amniocentesis. Materials and Methods: From January 1987 to September 2009, 31,194 amniocenteses were performed at Mackay ...
Chih-Ping Chen   +10 more
doaj   +1 more source

In Utero HSC Transplantation for Sickle Cell Disease: A Potential Therapeutic Approach That Overcomes Complications of Current Therapies

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Sickle cell disease (SCD) affects millions worldwide but has limited treatment options, most of which carry significant side effects. At present, the only curative treatment for SCD is allogeneic or gene‐modified autologous hematopoietic stem cell (HSC) transplantation (Tx).
Oluwaseun O. Babatunde   +4 more
wiley   +1 more source

Assessment of Second Trimester Genetic Amniocentesis: A Review of 6 Years of Experience at Sanpatong Hospital, A Mid-level Secondary Hospital Setting

open access: yesBiomedical Sciences and Clinical Medicine
OBJECTIVE This study aims to assess the indications, complications, and outcomes of second-trimester genetic amniocentesis performed at Sanpatong Hospital, Chiang Mai, Thailand.
Surachai Ponglopisit   +3 more
doaj   +1 more source

Impact of Second-Trimester Maternal Serum Screening on Prenatal Diagnosis of Down Syndrome and the use of Amniocentesis in the Taiwanese Population

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2005
Objective: To investigate the impact of second-trimester maternal serum screening on prenatal diagnosis of Down syndrome and the use of amniocentesis in the Taiwanese population.
Chih-Ping Chen   +2 more
doaj   +1 more source

An Economic Model of Amniocentesis Choice [PDF]

open access: yes
Medical practitioners typically utilize the following protocol when advising pregnant women about testing for the possibility of genetic disorders: Pregnant women over the age of 35 should be tested for Down syndrome and other genetic disorders; for ...
V. Joseph Hotz   +2 more
core  

Home - About - Disclaimer - Privacy